The Leverkusen-based conglomerate is executing on multiple fronts at once — trimming leverage through a private equity partnership, rolling out new crop protection products, and navigating the final procedural steps of its Roundup litigation. For investors, the picture emerging is one of incremental progress rather than dramatic inflection.
Apollo Transaction Reshapes the Balance Sheet
The most tangible near-term catalyst is the previously announced agreement with Apollo Global Management, struck in July, which is expected to close during the third quarter. Apollo is taking a minority stake in a newly formed entity housing Bayer’s LARC contraception franchise, injecting €3.0 billion in fresh equity while Bayer…